Literature DB >> 2677982

Antimicrobial therapy for lower respiratory tract infections.

P J van den Broek1.   

Abstract

The principles of antimicrobial therapy of lower respiratory tract infections are discussed. Making a differential diagnosis of possible causative agents of an infection is the corner-stone of rational antimicrobial therapy. Antimicrobial therapy should only be instituted when the patient will benefit from the treatment, which can not be taken for granted in the case of bronchitis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2677982     DOI: 10.1007/bf01987954

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  7 in total

1.  Evolution and epidemiology of MLS resistance.

Authors:  J Duval
Journal:  J Antimicrob Chemother       Date:  1985-07       Impact factor: 5.790

2.  Pneumococcaemia caused by erythromycin-resistant Streptococcus pneumoniae type 14.

Authors:  S J Eykyn
Journal:  Lancet       Date:  1988-11-05       Impact factor: 79.321

3.  Antibiotics for exacerbations of chronic bronchitis?

Authors: 
Journal:  Lancet       Date:  1987-07-04       Impact factor: 79.321

Review 4.  Bronchial tree penetration of antibiotics.

Authors:  B R Smith; J L LeFrock
Journal:  Chest       Date:  1983-06       Impact factor: 9.410

5.  The penetration of erythromycin into human bronchial mucosa.

Authors:  H Mattie; J J Hoogeterp; J P Kaajan; J Hermans
Journal:  Br J Clin Pharmacol       Date:  1987-08       Impact factor: 4.335

6.  Antibiotic therapy of acute exacerbations of chronic bronchitis. A controlled study using tetracycline.

Authors:  M B Nicotra; M Rivera; R J Awe
Journal:  Ann Intern Med       Date:  1982-07       Impact factor: 25.391

7.  Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.

Authors:  N R Anthonisen; J Manfreda; C P Warren; E S Hershfield; G K Harding; N A Nelson
Journal:  Ann Intern Med       Date:  1987-02       Impact factor: 25.391

  7 in total
  1 in total

Review 1.  Antibacterial treatment in exacerbations of chronic obstructive pulmonary disease. Pitfalls in study design and evaluation.

Authors:  W J Wijnands
Journal:  Pharm Weekbl Sci       Date:  1989-08-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.